[go: up one dir, main page]

AU2001295732A1 - Concatenated nucleic acid sequences - Google Patents

Concatenated nucleic acid sequences

Info

Publication number
AU2001295732A1
AU2001295732A1 AU2001295732A AU9573201A AU2001295732A1 AU 2001295732 A1 AU2001295732 A1 AU 2001295732A1 AU 2001295732 A AU2001295732 A AU 2001295732A AU 9573201 A AU9573201 A AU 9573201A AU 2001295732 A1 AU2001295732 A1 AU 2001295732A1
Authority
AU
Australia
Prior art keywords
nucleic acid
acid sequences
concatenated nucleic
concatenated
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295732A
Inventor
Laurent Jespers
Ignace Lasters
Peter Wang
Gregory Winter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domantis Ltd
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2001295732A1 publication Critical patent/AU2001295732A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001295732A 2000-10-13 2001-10-15 Concatenated nucleic acid sequences Abandoned AU2001295732A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0025144.7 2000-10-13
GB0025144 2000-10-13
GBGB0025144.7A GB0025144D0 (en) 2000-10-13 2000-10-13 Concatenated nucleic acid sequences
PCT/GB2001/004615 WO2002030945A2 (en) 2000-10-13 2001-10-15 Concatenated nucleic acid sequences

Publications (1)

Publication Number Publication Date
AU2001295732A1 true AU2001295732A1 (en) 2002-04-22

Family

ID=9901240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295732A Abandoned AU2001295732A1 (en) 2000-10-13 2001-10-15 Concatenated nucleic acid sequences

Country Status (5)

Country Link
US (1) US20040009507A1 (en)
EP (1) EP1325119A2 (en)
AU (1) AU2001295732A1 (en)
GB (1) GB0025144D0 (en)
WO (1) WO2002030945A2 (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871799B2 (en) 2002-11-22 2011-01-18 Lawrence Livermore National Security, Llc Sequential addition of short DNA oligos in DNA-polymerase-based synthesis reactions
CA2525120C (en) 2003-05-14 2013-04-30 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
MY146381A (en) 2004-12-22 2012-08-15 Amgen Inc Compositions and methods relating relating to anti-igf-1 receptor antibodies
CL2007002567A1 (en) 2006-09-08 2008-02-01 Amgen Inc ISOLATED PROTEINS FROM LINK TO ACTIVINE TO HUMAN.
JP2008289483A (en) * 2007-05-25 2008-12-04 Symphogen As Screening of transformant expressable in eukaryote system
CL2008001887A1 (en) 2007-06-29 2008-10-03 Amgen Inc PROTEINS OF UNION TO ANTIGEN THAT JOIN THE RECEPTOR ACTIVATED BY PROTEASES 2 (PAR-2); NUCLEIC ACID THAT CODES THEM; VECTOR AND GUEST CELL; METHOD OF PRODUCTION; AND COMPOSITION THAT UNDERSTANDS THEM.
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
US8017328B2 (en) * 2008-11-21 2011-09-13 Agilent Technologies, Inc. Genome partitioning using a nicking endonuclease
CN102388068B (en) 2009-03-20 2015-05-20 安姆根有限公司 Alpha-4-beta-7 heterodimer specific antagonist antibody
AU2010278959A1 (en) 2009-07-31 2012-02-02 Amgen Inc. Polypeptides that bind tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methods
EP2491123B1 (en) * 2009-10-20 2018-04-18 The Regents of The University of California Single molecule nucleic acid nanoparticles
UA109888C2 (en) 2009-12-07 2015-10-26 ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES
EP2558497A2 (en) 2010-04-15 2013-02-20 Amgen Inc. Human fgf receptor and beta-klotho binding proteins
SG10201506405YA (en) 2010-08-16 2015-10-29 Amgen Inc Polypeptides That Bind Myostatin, Compositions And Methods
JP2014510265A (en) 2011-02-02 2014-04-24 アムジェン インコーポレイテッド Methods and compositions for inhibition of IGF-IR
US9574002B2 (en) 2011-06-06 2017-02-21 Amgen Inc. Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
KR102091294B1 (en) 2011-10-26 2020-04-16 암젠 인크 Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light
WO2013169734A1 (en) 2012-05-07 2013-11-14 Amgen Inc. Anti-erythropoietin antibodies
US9175082B2 (en) 2012-05-31 2015-11-03 Sorrento Therapeutics, Inc. Antigen binding proteins that bind PD-L1
CA2877573A1 (en) 2012-06-21 2013-12-27 Sorrento Therapeutics, Inc. Antigen binding proteins that bind c-met
HK1208236A1 (en) 2012-06-22 2016-02-26 Sorrento Therapeutics, Inc. Antigen binding proteins that bind ccr2
US20140004121A1 (en) 2012-06-27 2014-01-02 Amgen Inc. Anti-mesothelin binding proteins
WO2014022102A1 (en) 2012-08-01 2014-02-06 Amgen Inc. Methods of using anti-apoptotic compounds to modulate one or more properties of a cell culture
US20150353542A1 (en) 2013-01-14 2015-12-10 Amgen Inc. Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture
EP3985024A1 (en) 2013-02-01 2022-04-20 Atara Biotherapeutics, Inc. Anti-activin-a compounds for the treatment of ovarian cancer
AU2014249458A1 (en) 2013-03-11 2015-09-24 Amgen Inc. Protein formulations
EP2970451A1 (en) 2013-03-14 2016-01-20 Amgen Inc. Chrdl-1 antigen binding proteins and methods of treatment
WO2015066357A1 (en) 2013-10-31 2015-05-07 Amgen Inc. Use of monensin to regulate glycosylation of recombinant proteins
US10106829B2 (en) 2014-01-29 2018-10-23 Amgen Inc. Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
EA037565B1 (en) 2014-01-29 2021-04-14 Эмджен Инк. Method for decreasing the high mannose glycoform content of a recombinant protein
WO2016028523A2 (en) 2014-08-22 2016-02-25 Sorrento Therapeutics, Inc. Antigen binding proteins that bind cxcr3
WO2016040767A2 (en) 2014-09-12 2016-03-17 Amgen Inc. Chrdl-1 epitopes and antibodies
AU2015331602A1 (en) 2014-10-17 2017-04-27 Amgen Inc. Antibodies directed to angiopoietin-1 and angiopoietin-2 for ocular therapies
CN105669863B (en) 2014-12-05 2019-09-13 鸿运华宁（杭州）生物医药有限公司 An antibody that can specifically bind to human endothelin receptor and its application
JP6917902B2 (en) 2015-02-13 2021-08-11 ソレント・セラピューティクス・インコーポレイテッド Antibody drug that binds to CTLA4
US10100126B2 (en) 2015-03-10 2018-10-16 Sorrento Therapeutics, Inc. Antibody therapeutics that bind PSMA
ES2927119T3 (en) 2015-04-08 2022-11-02 Sorrento Therapeutics Inc Antibody therapeutics that bind to CD38
WO2017058944A1 (en) 2015-09-29 2017-04-06 Amgen Inc. Asgr inhibitors
BR112018015480A2 (en) 2016-01-29 2019-05-21 Sorrento Therapeutics, Inc. pd-l1-binding antigen binding proteins
IL300591A (en) 2016-05-11 2023-04-01 Amgen Inc Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors
TWI826351B (en) 2016-05-31 2023-12-21 大陸商鴻運華寧（杭州）生物醫藥有限公司 R antibodies, their pharmaceutical compositions and uses
CN117126279A (en) 2018-03-20 2023-11-28 鸿运华宁（杭州）生物医药有限公司 GIPR antibody and fusion protein of GIPR antibody and GLP-1, and pharmaceutical composition and application thereof
CN110357959B (en) 2018-04-10 2023-02-28 鸿运华宁（杭州）生物医药有限公司 GCGR antibody, fusion protein of GCGR antibody and GLP-1, and pharmaceutical composition and application of GCGR antibody and fusion protein
CN110655577A (en) 2018-06-13 2020-01-07 鸿运华宁（杭州）生物医药有限公司 APJ antibody and its fusion protein with Elabela, and pharmaceutical compositions and applications thereof
CA3130449A1 (en) 2019-04-30 2020-11-05 Gigagen, Inc. Recombinant polyclonal proteins and methods of use thereof
CN112239507A (en) 2019-07-17 2021-01-19 鸿运华宁（杭州）生物医药有限公司 Fusion protein of ETA antibody and TGF-β Trap, and its pharmaceutical composition and application
CN112521501A (en) 2019-09-18 2021-03-19 鸿运华宁（杭州）生物医药有限公司 GIPR antibody and fusion protein thereof with GLP-1, and pharmaceutical composition and application thereof
TW202134280A (en) 2019-12-05 2021-09-16 美商索倫多醫療公司 Compositions and methods comprising an anti-cd47 antibody in combination with a tumor targeting antibody
EP4110817A1 (en) 2020-02-26 2023-01-04 Sorrento Therapeutics, Inc. Activatable antigen binding proteins with universal masking moieties
WO2021195089A1 (en) 2020-03-23 2021-09-30 Sorrento Therapeutics, Inc. Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof
CN115943310A (en) 2020-04-24 2023-04-07 索伦托药业有限公司 Lateral Flow Device for Detection of Anti-SARS-COV-2 Neutralizing Antibodies
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
CA3177152A1 (en) 2020-06-12 2021-12-16 David Scott Johnson Recombinant polyclonal proteins targeting covid-19 and methods of use thereof
CA3183034A1 (en) 2020-06-26 2021-12-30 Heyue Zhou Anti-pd1 antibodies and uses thereof
WO2022031834A1 (en) 2020-08-05 2022-02-10 Gigagen, Inc. Recombinant polyclonal proteins targeting zika and methods of use thereof
TW202233660A (en) 2020-10-30 2022-09-01 美商安進公司 Overexpression of insulin-like growth factor receptor mutants to modulate igf supplementation
WO2022098782A1 (en) 2020-11-04 2022-05-12 Sorrento Therapeutics, Inc. Lateral flow devices for high sensitivity detection of coronavirus infection, and methods of making and using the same
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
CN115141276A (en) 2021-03-31 2022-10-04 鸿运华宁（杭州）生物医药有限公司 Antibody capable of being specifically combined with human endothelin receptor and application thereof in treatment of diabetic nephropathy and chronic nephropathy
AU2022290563A1 (en) 2021-06-09 2024-01-25 Sofusa Holdings Llc Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
TW202328442A (en) 2021-09-10 2023-07-16 美商安進公司 Adaptation of platform hosts to igf- media
CN117659189A (en) 2022-09-08 2024-03-08 鸿运华宁（杭州）生物医药有限公司 GIPR antibodies and their fusion proteins with FGF21, as well as pharmaceutical compositions and applications thereof
WO2025015044A1 (en) 2023-07-11 2025-01-16 Amgen Inc. Alternating recirculating tangential flow (artf) filtration for cell culture media perfusion and bioreactor harvesting
WO2025024295A1 (en) 2023-07-21 2025-01-30 Amgen Inc. Vectors incorporating a combination of promoters driving selectable marker expression
TW202515895A (en) 2023-08-15 2025-04-16 美商吉加根公司 Recombinant polyclonal proteins targeting hepatitis b virus (hbv) and methods of use thereof
WO2025085682A1 (en) 2023-10-18 2025-04-24 Amgen Inc. Evaluation of mrna transcript levels using ddpcr for early pool and single-cell clone assessment in cell line development
WO2025129128A1 (en) 2023-12-15 2025-06-19 Vivasor, Inc. Compositions and methods for non-viral delivery of therapeutic compounds
WO2025155774A2 (en) 2024-01-19 2025-07-24 Amgen Inc. Vector engineering strategies to enhance volumetric productivity and decrease impurity formation across a diverse set of modalities
WO2025155776A1 (en) 2024-01-19 2025-07-24 Amgen Inc. Expression vector systems with two copies of light chain
WO2025184493A1 (en) 2024-02-29 2025-09-04 Amgen Inc. Dual selection expression vector systems for multi-chain biologics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4403036A (en) * 1980-12-02 1983-09-06 University Of Iowa Research Foundation Genetic reagents for generating plasmids containing multiple copies of DNA segments
US5830713A (en) * 1986-11-04 1998-11-03 Protein Polymer Technologies, Inc. Methods for preparing synthetic repetitive DNA
US5030566A (en) * 1989-01-04 1991-07-09 Board Of Regents, The University Of Texas System Concatemeric DNA length standards
US5023171A (en) * 1989-08-10 1991-06-11 Mayo Foundation For Medical Education And Research Method for gene splicing by overlap extension using the polymerase chain reaction
DE3936258C1 (en) * 1989-10-31 1991-04-25 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De
WO1993011236A1 (en) * 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
JPH07507201A (en) * 1992-03-10 1995-08-10 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，アズ　レプリゼンテッド　バイ　ザ　セクレタリー，デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ variable template reaction
DE4428651C1 (en) * 1994-08-12 1996-02-29 Inst Molekulare Biotechnologie Process for the production and amplification of nucleic acids
US5648245A (en) * 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
FR2738841B1 (en) * 1995-09-15 1997-11-21 Centre Nat Rech Scient PROCESS FOR THE POLYMERIZATION OF NUCLEIC ACID SEQUENCES AND ITS APPLICATIONS
US5756316A (en) * 1995-11-02 1998-05-26 Genencor International, Inc. Molecular cloning by multimerization of plasmids
ES2262902T3 (en) * 1995-12-05 2006-12-01 Jorn Erland Koch A REACTION IN CASCADE OF AMPLIFICATION OF NUCLEIC ACID.
JP3415995B2 (en) * 1996-06-10 2003-06-09 科学技術振興事業団 Method for producing high molecular micro gene polymer
GB0018120D0 (en) * 2000-07-24 2000-09-13 Fermentas Ab Nuclease

Also Published As

Publication number Publication date
EP1325119A2 (en) 2003-07-09
WO2002030945A2 (en) 2002-04-18
GB0025144D0 (en) 2000-11-29
US20040009507A1 (en) 2004-01-15
WO2002030945A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2001295732A1 (en) Concatenated nucleic acid sequences
AU2002245184A1 (en) Nucleic acid amplification
AU2002325538A1 (en) Nucleic acid amplification methods
AU2002257076A1 (en) Nucleic acid shuffling
AU2001249098A1 (en) Nucleic acid sequences associated with aging, particularly skin aging
AU2001261476A1 (en) Nucleic acid sequences for novel gpcrs
AU2001242625A1 (en) Gene sequence
AU2003281867A1 (en) Antisense nucleic acids
AU2001240791A1 (en) Sequence
AU2001278655A1 (en) Novel nucleic acid and amino acid sequences
AU2001264247A1 (en) GASC1 gene
AU2001240103A1 (en) Reproduction-specific genes
WO2001098454A8 (en) Human dna sequences
AU2002366435A1 (en) Nucleic acid amplification
AU2001288839A1 (en) Self-rearranging dna vectors
AU2002310296A1 (en) Rna purification methods
AUPQ749100A0 (en) New epilespy gene
AU2001252390A1 (en) Nucleic acid immunization
AU2001285743A1 (en) Adipose-related gene
AU7461900A (en) Nucleotide sequences
AU2001253485A1 (en) Nucleic acid sequences associated with baldness
AU2001276406A1 (en) Apoptosis-inducing dna sequences
AUPR223500A0 (en) Nucleic acid sequence
AU2002314927A1 (en) Nucleic acid regulatory sequences and uses therefor
AU1051701A (en) Catalytic nucleic acid sequences